Chemically and Biologically Engineered Bacteria-Based Delivery Systems for Emerging Diagnosis and Advanced Therapy

Area of Science:

• Microbiology and Biotechnology
• Biomedical Engineering
• Drug Delivery Systems

Background:

• Bacteria play a crucial role in human health and disease.
• Chemical biotechnology enables the use of bacteria as novel delivery systems.
• Bacteria possess unique properties like biocompatibility and motility for biomedical uses.

Purpose of the Study:

• To review the synergy between chemical biotechnology and bacteria for biomedical applications.
• To discuss the design principles of bacteria-based delivery systems.
• To highlight advances in the diagnosis and therapy of diseases using bacteria.

Main Methods:

• Review of current literature on bacteria-based delivery systems.
• Analysis of chemical biotechnology integration with bacterial platforms.
• Exploration of microbial modulation strategies.
• Assessment of clinical translation pathways.

Main Results:

• Bacteria engineered via chemical biotechnology show potential in treating cancer, infectious diseases, kidney failure, and hyperammonemia.
• Bacteria-based systems offer intrinsic biocompatibility and motility for targeted delivery.
• Research opportunities at the interface of chemical biotechnology and bacteria are expanding.
• Emerging advances focus on diagnostic and therapeutic applications.

Conclusions:

• The integration of chemical biotechnology with bacteria presents a promising approach for advanced biomedical applications.
• Bacteria-based delivery systems are being developed for diverse diagnostic and therapeutic purposes.
• Further research and clinical translation are key to realizing the full potential of these systems.